Plants obtained from conventional breeding can’t be patented, European patent court rules

| May 20, 2020
a ba a e e f dc e XL e
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

The highest judicial authority at the [European Patent Office] EPO issued their opinion …. in the controversial G3/19 (Pepper) case. Contrary to previous decisions in G2/12 and G2/13 (Tomato/Broccoli), the Enlarged Board of Appeal (EBA) has found that plant and animal products produced by essentially biological processes should NOT be patentable.

This U-turn is the end result of significant political pressure from across Europe in favor of farmers and breeders who consider that patents on plants obtained from conventional breeding methods will hinder their activities.

Importantly, this new interpretation will not have retroactive effect on European patents granted before 1st July 2017, or pending European applications that were filed before this date.

Related article:  Low trust in government tech regulation fuels consumer doubt about GMOs, gene editing

This case provides a definitive answer on patentability of animal and plant products resulting from conventional breeding at the EPO. The position will not come as a surprise, in light of the amendment to the Biotech Directive and, subsequently, the EPC. However, it will still be a blow to the Agritech industry, who will now need to rely more on plant variety rights for protecting innovations in this area.

Read the original post

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend